7,925
Views
11
CrossRef citations to date
0
Altmetric
Mental Health

Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective

, , , , , , , & show all
Pages 193-205 | Received 16 Sep 2021, Accepted 19 Jan 2022, Published online: 06 Feb 2022

References

  • Centers for Disease Control and Prevention (CDC). Attention-Deficit/Hyperactivity Disorder (ADHD): U.S. Department of Health & Human Services; 2021 [cited 2021 Jun 24]. Available from: https://www.cdc.gov/ncbddd/adhd/facts.html
  • Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). About ADHD; 2017. p. 1–6.
  • American Academy of Child & Adolescent Psychiatry. ADHD Parents Medication Guide; 2013. p. 1–45.
  • Child and Adolescent Health Measurement Initiative. 2018 National Survey of Children’s Health (NSCH) data query. Data Resource Center for Child and Adolescent Health supported by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB) [cited 2020 Feb 26]. Available from: www.childhealthdata.org.
  • Kessler RC, Avenevoli S, Costello EJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry. 2012;69(4):372–380.
  • Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163(4):716–723.
  • DuPaul GJ, Langberg JM. Educational impairments in children with ADHD. In: Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: The Guilford Press; 2015. p. 169–190.
  • Kuriyan AB, Pelham WE, Jr., Molina BS, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol. 2013;41(1):27–41.
  • Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99.
  • Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med. 2002;156(5):504–511.
  • Doshi JA, Hodgkins P, Kahle J, et al. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry. 2012;51(10):990–1002 e2.
  • Hakkaart-van Roijen L, Zwirs BW, Bouwmans C, et al. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007;16(5):316–326.
  • Fridman M, Banaschewski T, Sikirica V, et al. Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the caregiver perspective on pediatric ADHD survey in Europe. Neuropsychiatr Dis Treat. 2017;13:373–386.
  • Kleinman NL, Durkin M, Melkonian A, et al. Incremental employee health benefit costs, absence days, and turnover among employees with ADHD and among employees with children with ADHD. J Occup Environ Med. 2009;51(11):1247–1255.
  • Zhao X, Page TF, Altszuler AR, et al. Family burden of raising a child with ADHD. J Abnorm Child Psychol. 2019;47(8):1327–1338.
  • Chronis-Tuscano A, Wang CH, Woods KE, et al. Parent ADHD and evidence-based treatment for their children: review and directions for future research. J Abnorm Child Psychol. 2017;45(3):501–517.
  • Waxmonsky JG, Waschbusch DA, Babinski DE, et al. Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial. CNS Drugs. 2014;28(7):665–677.
  • Madsen KB, Ravn MH, Arnfred J, et al. Characteristics of undiagnosed children with parent-reported ADHD behaviour. Eur Child Adolesc Psychiatry. 2018;27(2):149–158.
  • Okumura Y, Yamasaki S, Ando S, et al. Psychosocial burden of undiagnosed persistent ADHD symptoms in 12-year-old children: a population-based birth cohort study. J Atten Disord. 2021;25(5):636–645.
  • Charach A, Yeung E, Climans T, et al. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative Meta-analyses. J Am Acad Child Adolesc Psychiatry. 2011;50(1):9–21.
  • Curry AE, Yerys BE, Metzger KB, et al. Traffic crashes, violations, and suspensions among young drivers with ADHD. Pediatrics. 2019;143(6):e20182305.
  • Molina BS, Pelham WE. Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497–507.
  • Thompson AL, Molina BS, Pelham W Jr, et al. Risky driving in adolescents and young adults with childhood ADHD. J Pediatr Psychol. 2007;32(7):745–759.
  • Sciberras E, Streatfeild J, Ceccato T, et al. Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan. J Atten Disord. 2022;26(1):72–87.
  • Wolraich ML, Hagan JF Jr., Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528.
  • Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304.
  • Kessler R, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593–602.
  • Sibley MH, Arnold LE, Swanson JM, et al. Variable patterns of remission from ADHD in the multimodal treatment study of ADHD. Am J Psychiatry. 2021. DOI:10.1176/appi.ajp.2021.21010032
  • Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed. 2006;8(3):12.
  • Arnold LE, Hodgkins P, Kahle J, et al. Long-term outcomes of ADHD: academic achievement and performance. J Atten Disord. 2020;24(1):73–85.
  • DuPaul GJ, Kern L, Gormley MJ, et al. Early intervention for young children with ADHD: academic outcomes for responders to behavioral treatment. School Mental Health. 2011;3(3):117–126.
  • Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007;32(6):643–654.
  • Polderman TJ, Boomsma DI, Bartels M, et al. A systematic review of prospective studies on attention problems and academic achievement. Acta Psychiatr Scand. 2010;122(4):271–284.
  • Gupte-Singh K, Singh RR, Lawson KA. Economic burden of attention-deficit/hyperactivity disorder among pediatric patients in the United States. Value Health. 2017;20(4):602–609.
  • Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost Eff Resour Alloc. 2005;3:5.
  • Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr. 2007;7(1 Suppl):121–131.
  • Kessler RC, Avenevoli S, Costello EJ, et al. Design and field procedures in the US national comorbidity survey replication adolescent supplement (NCS-A). Int J Methods Psychiatr Res. 2009;18(2):69–83.
  • United States Census Bureau. 2018 American Community Survey; 2019.
  • Danielson ML, Bitsko RH, Ghandour RM, et al. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199–212.
  • Xu G, Strathearn L, Liu B, et al. Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997-2016. JAMA Netw Open. 2018;1(4):e181471.
  • Agency for Healthcare Research and Quality. Mean expenditure per person with expense by insurance coverage, United States, 2017. Medical Expenditure Panel Survey; 2017.
  • United States Department of Health & Human Services. Estimates of funding for various research, condition, and disease categories (RCDC). Research Portfolio Online Reporting Tools; 2019.
  • Robb JA, Sibley MH, Pelham WE Jr., et al. The estimated annual cost of ADHD to the U.S. education system. School Ment Health. 2011;3(3):169–177.
  • Chambers JG, Parrish TB, Harr JJ. What are we spending on special education services in the United States, 1999–2000? Report. Special; 2002.
  • United States Census Bureau. Public elementary-secondary education finance data: per pupil amounts for current spending of public elementary-secondary school systems by state. Fiscal Year. 2017;2017.
  • Molina BS, Pelham WE, Gnagy EM, et al. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res. 2007;31(4):643–654.
  • Sacks JJ, Gonzales KR, Bouchery EE, et al. 2010 National and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73–e79.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2018 national survey on drug use and health: detailed tables. Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health; 2019.
  • US Department of Justice National Drug Intelligence Center. The economic impact of illicit drug use on American Society; 2011.
  • National Highway Traffic Safety Administration. Police-reported motor vehicle crashes in 2018, traffic safety facts; 2019.
  • National Highway Traffic Safety Administration. The economic and societal impact of motor vehicle crashes, 2010 (Revised); 2015.
  • Robinson R. Cost-benefit analysis. BMJ. 1993;307(6909):924–926.
  • Ramtekkar UP, Reiersen AM, Todorov AA, et al. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217–228 e1–3.
  • United States Census Bureau. Employment status of the civilian noninstitutional population by age, sex, and race [cited 2020 Feb 27]. Available from: https://data.census.gov/cedsci/table?q=unemployment&hidePreview=false&tid=ACSST1Y2018.S2301&vintage=2018
  • United States Census Bureau. Work experience-people 15 years old and over, by total money earnings, age, race, hispanic origin, sex, and disability status; 2018.
  • Kessler RC, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47(6):565–572.
  • Dalsgaard S, Ostergaard SD, Leckman JF, et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;385(9983):2190–2196.
  • Kochanek KD, Murphy SL, Xu J, et al. Deaths: final data for 2017: national vital statistics reports, US Department of Health & Human Services, Centers for Disease Control and Prevention, USA; 2019 [cited 2019 Oct 14]. Available from: https://stacks.cdc.gov/view/cdc/79486
  • Adler LA, Childress A, Cloutier M, et al. Economic burden of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in the United States (US): a societal perspective. Value in Health. 2021;24(1):S6–S7.
  • American Heart Association. Cardiovascular disease: a costly burden for America projections through 2035; 2017.
  • Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77(6):764–771.
  • Cloutier M, Greene M, Guerin A, et al. The economic burden of bipolar I disorder in the United States in 2015. J Affect Disord. 2018;226:45–51.
  • Davis LL, Schein J, Cloutier M, et al. The economic burden of post-traumatic stress disorder in the United States from a societal perspective. J Manag Care Spec Pharm. 2021;27(4-a Suppl):S61.
  • DuPont RL, Rice DP, Miller LS, et al. Economic costs of anxiety disorders. Anxiety. 1996;2(4):167–172.
  • Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54(11):405–418.
  • Pokhilenko I, Janssen LMM, Evers S, et al. Do costs in the education sector matter? A systematic literature review of the economic impact of psychosocial problems on the education sector. Pharmacoeconomics. 2021;39(8):889–900.
  • Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114(5):e541–e547.
  • LeFever GB, Villers MS, Morrow AL, et al. Parental perceptions of adverse educational outcomes among children diagnosed and treated for ADHD: a call for improved school/provider collaboration. Psychol Schs. 2002;39(1):63–71.
  • Jones DE, Foster EM, Conduct Problems Prevention Research Group. Service use patterns for adolescents with ADHD and comorbid conduct disorder. J Behav Health Serv Res. 2009;36(4):436–449.
  • Barbaresi WJ, Katusic SK, Colligan RC, et al. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28(4):274–287.
  • Rapport MD, Denney C, DuPaul GJ, et al. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry. 1994;33(6):882–893.
  • Suzer Gamli I, Tahiroglu AY. Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study. Neuropsychiatr Dis Treat. 2018;14:1329–1337.
  • Biederman J, Fried R, DiSalvo M, et al. Evidence of low adherence to stimulant medication among children and youths with ADHD: an electronic health records study. Psychiatr Serv. 2019;70(10):874–880.
  • Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–567.
  • Wong IC, Asherson P, Bilbow A, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)–a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009;13(50):iii–iv, ix–xi, 1–120.
  • Gajria K, Lu M, Sikirica V, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatr Dis Treat. 2014;10:1543–1569.
  • Beau-Lejdstrom R, Douglas I, Evans SJ, et al. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open. 2016;6(6):e010508.
  • Faraone SV, Antshel KM. Towards an evidence-based taxonomy of nonpharmacologic treatments for ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):965–972.
  • Centers for Medicare & Medicaid Services (CMS) Medicaid Program Integrity Education (MPIE). Stimulant and related medications: use in pediatric patients. 2015; p. 1–12.
  • Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–191.
  • US Government Accountability Office (GAO). Drug shortages: Better management of the quota process for controlled substances needed; coordination between DEA and FDA should be improved. Washington, DC. 2015; p. 1–78.
  • Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health. 2010;46(3):209–217.
  • Murray DW, Molina BS, Glew K, et al. Prevalence and characteristics of school services for high school students with attention-deficit/hyperactivity disorder. School Ment Health. 2014;6(4):264–278.
  • DuPaul GJ, Jitendra AK, Volpe RJ, et al. Consultation-based academic interventions for children with ADHD: effects on reading and mathematics achievement. J Abnorm Child Psychol. 2006;34(5):635–648.
  • Morris SH, Nahmias A, Nissley-Tsiopinis J, et al. Research to practice: implementation of family school success for parents of children with ADHD. Cogn Behav Pract. 2019;26(3):535–546.
  • Cherkasova MV, Roy A, Molina BSG, et al. Review: Adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit/hyperactivity disorder followed into adulthood. J Am Acad Child Adolesc Psychiatry. 2021. DOI:10.1016/j.jaac.2021.05.019
  • Harrison AG, Rosenblum Y. ADHD documentation for students requesting accommodations at the postsecondary level: update on standards and diagnostic concerns. Can Fam Physician. 2010;56(8):761–765.
  • Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010;122(5):97–109.
  • Fletcher JM. The effects of childhood ADHD on adult labor market outcomes. Health Econ. 2014;23(2):159–181.
  • United States Census Bureau. Enrollment status of the population 3 years and over, by sex, age, race, hispanic origin, foreign born, and foreign-born parentage; 2018 [cited 2020 Apr 29]. Available from: www.census.gov/programs-surveys/cps.html